
SynBioBeta Speaker
Ryan Olf
ARIA
Programme Director
Ryan Olf is a physicist trained at Caltech and Berkeley with an expansive and insatiable curiosity for technology. Before becoming Programme Director of ARIA’s Precision Mitochondria Programme within the Bioenergetic Engineering opportunity space, he explored a wide range of ambitious projects—from creating the world’s lowest-entropy quantum gas and designing nanotube-based GLP-1 implants to automating gene therapy manufacturing and developing software tools.
Sessions Featuring
Ryan
This Year
•
-
Human Health
Government Agency Showcase #2
ARIA Pitches
Featuring

Ivan Jayapurna
ARIA
Programme Director

Ryan Olf
ARIA
Programme Director
Physicist chasing moonshots from quantum gases to biotech.

Alice Pettitt
ARIA
Frontier Specialist

Brian Wang
ARIA
Programme Director

Alex Smith
ARIA
Programme Specialist

Aayush Chadha
ARIA
Frontier Specialist
•
-
Human Health
Government Agency Showcase #2
ARIA Pitches
Featuring

Ivan Jayapurna
ARIA
Programme Director

Ryan Olf
ARIA
Programme Director
Physicist chasing moonshots from quantum gases to biotech.

Alice Pettitt
ARIA
Frontier Specialist

Brian Wang
ARIA
Programme Director

Alex Smith
ARIA
Programme Specialist

Aayush Chadha
ARIA
Frontier Specialist
•
-
Longevity
Mitochondrial Transplantation and Genome Editing: Engineering the Metabolic Engine of Complex Life
Mitochondria are often pigeon-holed as the "powerhouse of the cell", giving the false impression that their primary role is as an ATP generator passively responding to the energetic demands of their environment. This is far from the truth. The mitochondria exist as a dynamic network that senses, integrates, and transduces biochemical, energetic, and physical signals, and these signals shape cell fate, lifespan, cancer risk, and more. This session explores emerging tools and methods to edit the small, maternally-inherited, circular mitochondrial genome present in dozens-to-hundreds of copies per cell as a means to prevent mitochondrial disease and optimize metabolic fitness. Additionally, we will discuss the promise of mitochondrial transplantation methodologies as a therapeutic intervention and to discuss the possible routes for mitochondrial metabolic engineering and a range of synthetic developments.
Featuring

Mariëlle van Kooten
Powerhouse Bio
CEO
Mitochondrial bioengineer

Colwyn Headley
Stanford University
Instructor
Mitochondrial-transplantation researcher targetting aging-immune heart disease

Cecilia Giulivi
UC Davis
Professor

Ryan Olf
ARIA
Programme Director
Physicist chasing moonshots from quantum gases to biotech.

Gordon Freedman
MitoWorld
Publisher
Mitochondrial-medicine ecosystem builder
•
-
Longevity
Mitochondrial Transplantation and Genome Editing: Engineering the Metabolic Engine of Complex Life
Mitochondria are often pigeon-holed as the "powerhouse of the cell", giving the false impression that their primary role is as an ATP generator passively responding to the energetic demands of their environment. This is far from the truth. The mitochondria exist as a dynamic network that senses, integrates, and transduces biochemical, energetic, and physical signals, and these signals shape cell fate, lifespan, cancer risk, and more. This session explores emerging tools and methods to edit the small, maternally-inherited, circular mitochondrial genome present in dozens-to-hundreds of copies per cell as a means to prevent mitochondrial disease and optimize metabolic fitness. Additionally, we will discuss the promise of mitochondrial transplantation methodologies as a therapeutic intervention and to discuss the possible routes for mitochondrial metabolic engineering and a range of synthetic developments.
Featuring

Mariëlle van Kooten
Powerhouse Bio
CEO
Mitochondrial bioengineer

Colwyn Headley
Stanford University
Instructor
Mitochondrial-transplantation researcher targetting aging-immune heart disease

Cecilia Giulivi
UC Davis
Professor

Ryan Olf
ARIA
Programme Director
Physicist chasing moonshots from quantum gases to biotech.

Gordon Freedman
MitoWorld
Publisher
Mitochondrial-medicine ecosystem builder




































